Integer
ITGR | NYSE
$126.97
+$0.02 (+0.02%)
At close: Nov 16, 2026, 4:00 PM ET
$126.97
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 4:00 PM ET
Integer Company Profile
Company profile explainedCompany Profile
Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Key Executives
| Name | Position |
|---|---|
| Payman Khales | Chief Executive Officer, President & Director |
| Carol Russell | Vice President & Chief Information Officer |
| Diron Smith | Executive Vice President & Chief Financial Officer |
| Andrew Senn | President of Growth & Innovation |
| Jim Stephens | Executive Vice President of Special Projects |
| John Harris | President of Global Operations & Manufacturing Technology |
| Kirk K. Thor | Executive Vice President & Chief Human Resources Officer |
| Kristen Marie Stewart | Director of Investor Relations |
| Lindsay Krause Blackwood | Senior Vice President, General Counsel, Chief Ethics & Compliance Officer and Corporate Secretary |
| Tom Thomas | Vice President, Corporate Controller & Principal Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 29, 2026 | 10-Q | Quarterly Report |
| Oct 29, 2026 | 8-K | Current Report |
| Oct 26, 2026 | 4 | Filing |
| Oct 21, 2026 | 8-K | Current Report |
| Oct 15, 2026 | 3 | Filing |
| Oct 15, 2026 | 3 | Filing |
| Oct 14, 2026 | 8-K | Current Report |
| Oct 13, 2026 | SC 13D | Filing |
| Oct 02, 2026 | 8-K | Current Report |
| Sep 30, 2026 | 8-K | Current Report |
Integer
| Country | United States |
| IPO Date | Sep 29, 2000 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 11,000 |
| CEO | Payman Khales |
Contact Details
5830 Granite Parkway Plano,
Texas 75024 United States
Stock Details
| Ticker Symbol | ITGR |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001114483 |
| CUSIP Number | 45826H109 |
| ISIN Number | US45826H1095 |
| SIC Code | 3690 |
Recent News
- 19 days ago / zacks.comInteger (ITGR) Q3 Earnings and Revenues Miss Estimates
- 19 days ago / globenewswire.comInteger Holdings Corporation Reports Third Quarter 2026 Results
- 26 days ago / globenewswire.comInteger Holdings Corporation Stockholders Approve Proposals in Connection with KKR's Proposed Acquisition of Integer
- 1 month ago / zacks.comIs the Options Market Predicting a Spike in Integer Holdings Stock?
- 2 months ago / globenewswire.comInteger Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028
- 2 months ago / globenewswire.comInteger Receives Early Termination of Hart-Scott-Rodino Waiting Period for Pending Acquisition by KKR
- 2 months ago / zacks.comHere's Why You Should Retain Integer Holdings Stock in Your Portfolio
- 3 months ago / businesswire.comInteger Holdings Corporation Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ITGR
- 3 months ago / zacks.comInteger Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline
- 4 months ago / zacks.comCompared to Estimates, Integer (ITGR) Q2 Earnings: A Look at Key Metrics
Add to Watchlist
Select watchlists to add or remove ITGR